Enhanced Vascular Responses to Adrenomedullin in Mice Overexpressing Receptor-Activity–Modifying Protein 2
暂无分享,去创建一个
L. Poston | G. Douglas | D. Sugden | M. Marber | J. Götz | L. Ittner | W. Born | S. Brain | I. McFadzean | J. Fischer | R. Poston | K. Husmann | A. Grant | Z. Lázár | J. Clark | James E. Clark | N. Clark | C. Tam | N. Clark
[1] T. Fujita,et al. Adrenomedullin as a potent antioxidative and antiatherosclerotic substance. , 2005, Drug news & perspectives.
[2] K. Kitamura,et al. Adrenomedullin receptors: pharmacological features and possible pathophysiological roles , 2004, Peptides.
[3] S. Brain,et al. The calcitonin gene‐related peptide (CGRP) receptor antagonist BIBN4096BS blocks CGRP and adrenomedullin vasoactive responses in the microvasculature , 2004, British journal of pharmacology.
[4] S. Brain,et al. Vascular actions of calcitonin gene-related peptide and adrenomedullin. , 2004, Physiological reviews.
[5] S. Miyano,et al. Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator , 2004, FEBS letters.
[6] W. Born,et al. Three receptor-activity-modifying proteins define calcitonin gene-related peptide or adrenomedullin selectivity of the mouse calcitonin-like receptor in COS-7 cells. , 2003, Biochemical pharmacology.
[7] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[8] D. Smith,et al. CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22–52, CGRP8–37 and BIBN4096BS , 2003, British journal of pharmacology.
[9] K. Akimoto,et al. Upregulation of ligand, receptor system, and amidating activity of adrenomedullin in left ventricular hypertrophy of severely hypertensive rats: effects of angiotensin-converting enzyme inhibitors and diuretic , 2003, Journal of hypertension.
[10] H. Nishimatsu,et al. Adrenomedullin augments collateral development in response to acute ischemia. , 2003, Biochemical and biophysical research communications.
[11] K. Akimoto,et al. Ventricular Adrenomedullin System in the Transition From LVH to Heart Failure in Rats , 2003, Hypertension.
[12] H. Nishimatsu,et al. Endothelial responses of the aorta from adrenomedullin transgenic mice and knockout mice. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.
[13] W. Born,et al. Adrenomedullin selectivity of calcitonin-like receptor/receptor activity modifying proteins. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.
[14] D. Hay,et al. A comparison of the actions of BIBN4096BS and CGRP8–37 on CGRP and adrenomedullin receptors expressed on SK‐N‐MC, L6, Col 29 and Rat 2 cells , 2002, British journal of pharmacology.
[15] Patrick M. Sexton,et al. International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors , 2002, Pharmacological Reviews.
[16] J. Longmore,et al. Receptor Activity-modifying Protein 1 Determines the Species Selectivity of Non-peptide CGRP Receptor Antagonists* 210 , 2002, The Journal of Biological Chemistry.
[17] Y. Kurihara,et al. Evidence for the Physiological and Pathological Roles of Adrenomedullin from Genetic Engineering in Mice , 2001, Annals of the New York Academy of Sciences.
[18] R. Scollay,et al. Gene Therapy , 2001, Annals of the New York Academy of Sciences.
[19] H. Nishimatsu,et al. Vascular Abnormalities and Elevated Blood Pressure in Mice Lacking Adrenomedullin Gene , 2001, Circulation.
[20] T. Kawarabayashi,et al. Alteration of the adrenomedullin receptor components gene expression associated with the blood pressure in pregnancy-induced hypertension. , 2001, The Journal of clinical endocrinology and metabolism.
[21] S. Legon,et al. The calcitonin gene-related peptide (CGRP) antagonist CGRP8–37 blocks vasodilatation in inflamed rat skin: involvement of adrenomedullin in addition to CGRP , 2001, Neuroscience Letters.
[22] H. Nishimatsu,et al. Adrenomedullin Induces Endothelium-Dependent Vasorelaxation via the Phosphatidylinositol 3-Kinase/Akt-Dependent Pathway in Rat Aorta , 2001, Circulation research.
[23] R. Nitsch,et al. Oligodendroglial tau filament formation in transgenic mice expressing G272V tau , 2001, The European journal of neuroscience.
[24] T. Fujita,et al. Hypoxic induction of adrenomedullin in cultured human umbilical vein endothelial cells , 2001, Journal of hypertension.
[25] O. Smithies,et al. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] B. Brenner,et al. Increased gene expression of adrenomedullin and adrenomedullin-receptor complexes, receptor-activity modifying protein (RAMP)2 and calcitonin-receptor-like receptor (CRLR) in the hearts of rats with congestive heart failure. , 2000, Clinical science.
[27] N. Aiyar,et al. Vasodilatory Effect of Adrenomedullin in Mouse Aorta , 2000, Pharmacology.
[28] P. Sexton,et al. Mouse receptor-activity-modifying proteins 1, -2 and -3: amino acid sequence, expression and function , 2000, Molecular and Cellular Endocrinology.
[29] M. Mukoyama,et al. Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy. , 2000, Biochemical and biophysical research communications.
[30] K. Rudolf,et al. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist , 2000, British journal of pharmacology.
[31] Melanie G. Lee,et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.
[32] Y. Nikiforov,et al. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. , 1997, The Journal of clinical investigation.
[33] F. Pomerleau,et al. Mouse aorta: a preparation highly sensitive to the vasodilatory action of CGRP. , 1997, Journal of cardiovascular pharmacology.
[34] J. Burnett,et al. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. , 1995, Circulation.
[35] K. Kangawa,et al. Plasma adrenomedullin in various diseases and exercise-induced change in adrenomedullin in healthy subjects. , 1995, Internal medicine.
[36] H. Lippton,et al. Interaction of human adrenomedullin 13–52 with calcitonin gene‐related peptide receptors in the microvasculature of the rat and hamster , 1995, British journal of pharmacology.
[37] Y. Hirata,et al. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. , 1994, Endocrinology.
[38] T. Ishimitsu,et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. , 1994, The Journal of clinical investigation.
[39] N. Minamino,et al. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. , 1994, Biochemical and biophysical research communications.
[40] K. Kangawa,et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. , 1993, Biochemical and biophysical research communications.
[41] Akira,et al. Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). , 1989, The American journal of physiology.
[42] M. Mulvany,et al. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. , 1977, Circulation research.
[43] S. Brain,et al. The assessment of vasoactive properties of CGRP and adrenomedullin in the microvasculature , 2004, Journal of Molecular Neuroscience.
[44] S. Kato,et al. Adrenomedullin, an Endogenous Peptide, Counteracts Cardiovascular Damage , 2002, Circulation.
[45] W. Born,et al. Printed in U.S.A. Copyright © 1999 by The Endocrine Society A Receptor Activity Modifying Protein (RAMP)2- Dependent Adrenomedullin Receptor Is a Calcitonin Gene-Related Peptide Receptor when Coexpressed with , 2022 .